Urinary NGF, TGF-β1, TIMP-2 and bladder wall thickness predict neurourological findings in children with myelodysplasia

Journal of Urology

Volumn 191, Issue 1, 2014, Pages 199-205

  Şekerci, Çagri Akin ^a   Işbilen, Banu ^b   Işman, Ferruh ^b   Akbal, Cem ^a   Şimşek, Ferruh ^a   Tarcan, Tufan ^a  

^a MARMARA UNIVERSITY   (Turkey)

^b GOZTEPE TRAINING AND RESEARCH HOSPITAL   (Turkey)

Author keywords

nerve growth factor; neural tube defects; neurogenic; tissue inhibitor of metalloproteinase 2; transforming growth factor beta1; urinary bladder

Indexed keywords

NERVE GROWTH FACTOR; SUCCIMER; TISSUE INHIBITOR OF METALLOPROTEINASE 2; TRANSFORMING GROWTH FACTOR BETA1; ANTIBIOTIC AGENT; BOTULINUM TOXIN A; CHOLINERGIC RECEPTOR BLOCKING AGENT;

ARTICLE; BLADDER WALL; CHILD; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MYELODYSPLASTIC SYNDROME; NEUROLOGIC EXAMINATION; PREDICTIVE VALUE; PRIORITY JOURNAL; SCHOOL CHILD; SCINTIGRAPHY; URINALYSIS; URINARY TRACT INJURY; URINE LEVEL; URODYNAMICS; ADOLESCENT; ANTIBIOTIC PROPHYLAXIS; BLADDER WALL THICKNESS; BRAIN VENTRICLE PERITONEUM SHUNT; CHILDHOOD DISEASE; CLEAN INTERMITTENT CATHETERIZATION; DERMAL SINUS; DIAGNOSTIC TEST ACCURACY STUDY; DIASTEMATOMYELIA; DIMERCAPTOSUCCINIC ACID SCINTIGRAPHY; ENZYME LINKED IMMUNOSORBENT ASSAY; HYDROMYELIA; INTERMITTENT CATHETERIZATION; KIDNEY SCINTISCANNING; LIPOMYELOMENINGOCELE; MENINGOCELE; MENINGOMYELOCELE; PREDICTION; PROTEIN URINE LEVEL; SCAR FORMATION; SENSITIVITY AND SPECIFICITY; SPINAL CORD MALFORMATION; SPLIT CORD MALFORMATION; SYRINGOMYELIA; TETHERED CORD SYNDROME; UROGENITAL SYSTEM PARAMETERS; VESICOURETERAL REFLUX;

BLADDER WALL THICKNESS; BONT-A; BOTULINUM NEUROTOXIN A; BWT; CIC; CLEAN INTERMITTENT CATHETERIZATION; DETRUSOR LEAK POINT PRESSURE; DIMERCAPTO-SUCCINIC ACID; DLPP; DMSA; MATRIX METALLOPROTEINASE; MMP; NERVE GROWTH FACTOR; NEURAL TUBE DEFECTS; NEUROGENIC; NGF; TGF-Β1; TIMP; TISSUE INHIBITOR OF METALLOPROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE-2; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR-Β1; URINARY BLADDER; VESICOURETERAL REFLUX; VUR;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; MALE; NERVE GROWTH FACTOR; NEURAL TUBE DEFECTS; ORGAN SIZE; TISSUE INHIBITOR OF METALLOPROTEINASE-2; TRANSFORMING GROWTH FACTOR BETA1; URINARY BLADDER; URINARY BLADDER, NEUROGENIC; URODYNAMICS;

EID: 84890106852     PISSN: 00225347     EISSN: 15273792     Source Type: Journal    
DOI: 10.1016/j.juro.2013.08.025     Document Type: Article

References (27)

1. Kataria R, Bajpai M, Lall A, et al. Neurogenic bladder: urodynamic and surgical aspects. Indian J Pediatr, suppl., 1997; 64: 68.
2. S.B. Bauer Neurogenic bladder: etiology and assessment Pediatr Nephrol 23 2008 541
3. C.J. Hodson, Z. Davies, and A. Prescod Renal parenchymal radiographic measurement in infants and children Pediatr Radiol 3 1975 16
4. J.R. Cogley, S.C. O'Connor, and R. Houshyar Emergent pediatric US: what every radiologist should know Radiographics 32 2012 651
5. J.C. Kim, E.Y. Park, and S.H. Hong Changes of urinary nerve growth factor and prostaglandins in male patients with overactive bladder symptom Int J Urol 12 2005 875
6. S.R. Lee, C.H. Hong, and Y.D. Choi Increased urinary nerve growth factor as a predictor of persistent detrusor overactivity after bladder outlet obstruction relief in a rat model J Urol 183 2010 2440
7. H.T. Liu, P. Tyagi, and M.B. Chancellor Urinary nerve growth factor level is increased in patients with interstitial cystitis/bladder pain syndrome and decreased in responders to treatment BJU Int 104 2009 1476
8. S. Ishidoya, J. Morrissey, and R. McCracken Angiotensin II receptor antagonist ameliorates renal tubulointerstitial fibrosis caused by unilateral ureteral obstruction Kidney Int 47 1995 1285
9. J.F. Woessner Jr. Matrix metalloproteinase inhibition. From the Jurassic to the third millennium Ann N Y Acad Sci 878 1999 388
10. H. Tanaka, M. Matsuda, and K. Moriya Ultrasonographic measurement of bladder wall thickness as a risk factor for upper urinary tract deterioration in children with myelodysplasia J Urol 180 2008 312
11. A. Cvitković-Kuzmić, B. Brkljacić, and D. Ivanković Ultrasound assessment of detrusor muscle thickness in children with non-neuropathic bladder/sphincter dysfunction Eur Urol 41 2002 214
12. L. Müller, K. Abrahamsson, and U. Sillén Ultrasound assessment of detrusor thickness in children and young adults with myelomeningocele J Urol 175 2006 704
13. L. Müller, B. Jacobsson, and S. Mårild Detrusor thickness in healthy children assessed by a standardized ultrasound method J Urol 166 2001 2364
14. G. FaydacI, F. Tarhan, and A.E. Gül Role of nerve growth factor receptor on bladder outlet obstruction Turk J Urol 30 2004 72
15. D. Creedon, and J.B. Tuttle Nerve growth factor synthesis in vascular smooth muscle Hypertension 18 1991 730
16. K. Persson, W.D. Steers, and J.B. Tuttle Regulation of nerve growth factor secretion in smooth muscle cells cultured from rat bladder body, base and urethra J Urol 157 1997 2000
17. W.D. Steers, S. Kolbeck, and D. Creedon Nerve growth factor in the urinary bladder of the adult regulates neuronal form and function J Clin Invest 88 1991 1709
18. E.M. Lowe, P. Anand, and G. Terenghi Increased nerve growth factor levels in the urinary bladder of women with idiopathic sensory urgency and interstitial cystitis Br J Urol 79 1997 572
19. B. Schnegelsberg, T.T. Sun, and G. Cain Overexpression of NGF in mouse urothelium leads to neuronal hyperinnervation, pelvic sensitivity, and changes in urinary bladder function Am J Physiol Regul Integr Comp Physiol 298 2010 R534
20. T. Antunes-Lopes, R. Pinto, and S.C. Barros Urinary neurotrophic factors in healthy individuals and patients with overactive bladder J Urol 189 2013 359
21. H.T. Liu, M.B. Chancellor, and H.C. Kuo Urinary nerve growth factor levels are elevated in patients with detrusor overactivity and decreased in responders to detrusor botulinum toxin-A injection Eur Urol 56 2009 700
22. H.T. Liu, and H.C. Kuo Urinary nerve growth factor levels are increased in patients with bladder outlet obstruction with overactive bladder symptoms and reduced after successful medical treatment Urology 72 2008 104
23. M.A. Taha, A.A. Shokeir, and H.G. Osman Pelvi-ureteric junction obstruction in children: the role of urinary transforming growth factor-beta and epidermal growth factor BJU Int 99 2007 899
24. C. Sager, J.C. Lopez, and V. Duran Transforming growth factor-beta1 in congenital ureteropelvic junction obstruction: diagnosis and follow-up Int Braz J Urol 35 2009 315
25. J. Zieg, K. Blahova, and T. Seeman Urinary transforming growth factor-beta1 in children with obstructive uropathy Nephrology 16 2011 595
26. R. Visse, and H. Nagase Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry Circ Res 92 2003 827
27. J.F. Woessner Jr. Matrix metalloproteinases and their inhibitors in connective tissue remodeling FASEB J 5 1991 2145